DE:ECQ0 Stock Latest News
Company AnnouncementsNeurizon Redeems 750,000 Convertible Notes Without Conversion2h ago
Company AnnouncementsNeurizon Eliminates Convertible Note Dilution2h ago
Company AnnouncementsNeurizon Proposes Issue of Up to 92.6 Million Shares2h ago
Company AnnouncementsNeurizon Raises A$4.3 Million and Simplifies Funding Structure2h ago
Company AnnouncementsNeurizon Therapeutics Halts Trading Ahead of Capital Raising Outcome4d ago
Company AnnouncementsNeurizon Advances NUZ-001 ALS Program With Full Trial Enrolment and Strengthened Funding5d agoCompany AnnouncementsNeurizon Therapeutics Sets Hybrid AGM, Moves to Digital-First Shareholder Communications6d ago
Company AnnouncementsNeurizon Therapeutics Trims Future Dilution as Options and Rights Lapse2w ago
Company AnnouncementsNeurizon updates investors on NUZ-001 strategy and plans ALS trial milestones3w ago
Company AnnouncementsFDA Feedback Positions Neurizon’s ALS Trial as Potentially Registrational3w ago- Company AnnouncementsNeurizon Director Boosts Shareholding in On-Market Purchase1M ago
Company AnnouncementsNeurizon Therapeutics Redeems 1 Million Convertible Notes Without Conversion1M agoCompany AnnouncementsNeurizon Cuts Convertible Notes and Locks In Standstill as HEALEY ALS Trial Funding Secured1M ago
Company AnnouncementsNIH Backs Neurizon’s NUZ-001 ALS Access Program With Multimillion-Dollar Grant1M ago
Company AnnouncementsNeurizon names seasoned pharma executive Chris Bremer as CEO ahead of key ALS trial readout1M ago
Company AnnouncementsNeurizon Therapeutics Expands ASX Quoted Share Base2M ago- Company AnnouncementsNeurizon Therapeutics files ASX governance disclosure for 20262M ago
Company AnnouncementsNeurizon Therapeutics Narrows Loss and Strengthens Balance Sheet in 20262M agoCompany AnnouncementsNeurizon Therapeutics Issues Large Tranche of Unquoted Incentive Securities2M ago
Company AnnouncementsNeurizon strengthens Elanco alliance with appointment of new Board observer2M ago